Project Details
Description
Excitatory amino acid transporters (EAATs) contribute to the regulation of central nervous system
neurotransmission by rapidly removing synaptically-released glutamate from the extracellular space.
The long-term goal of this proposal is to continue research towards the understanding of the
fundamental principles by which these transporters work. Although progress has been made towards
this goal by the functional characterization of several of the five cloned transporters (EAATs 1-5) and
the recent development of a structural model of glutamate transporters based on the x-ray structure
of the bacterial aspartate transporter, GltPh, important questions about the actual transport
mechanism, the functional sites of cation interaction, and the function and regulation of the glutamate
transporter subtype EAAT5 remain unresolved. These questions will be addressed by undertaking
research towards three specific aims. Aim 1 will characterize the mechanism(s) underlying the
separable movements of K+ and Na+/glutamate across the membrane. The hypothesis to be tested is
that K+ outward movement, as well as the independently-occurring Na+/glutamate translocation (the
actual step(s) of moving Na+ and glutamate across the membrane) are voltage-dependent, multi-step
processes, occurring through intermediate(s) on the translocation pathway. Aim 2 will identify
structural elements of mammalian glutamate transporters contributing to their interaction with cations.
Two hypotheses, both related to different aspects of the mechanism of cation interaction with EAATs
will be tested: a) Only one of the two cation binding sites of GltPh corresponds to a Na+ binding site of
mammalian EAATs; b) cation binding site(s) exist on mammalian EAATs that are not present in the
GltPh structure. Aim 3 will identify the mechanistic basis of EAAT5¿s low transport activity, and of the
regulation of its cell surface expression. The hypothesis to be tested is that EAAT5 is a slowly-gated
anion channel with little transport activity, in contrast to EAAT3 and EAAT4, which both readily
transport glutamate. To approach these three aims, wild-type glutamate transporters and
transporters with point mutations to cation binding sites predicted from empirical valence mapping will
be expressed in HEK293 cells, followed by functional analysis using uptake assays and transport
current recording with < 100 ms time resolution, allowing us to follow the dynamics of transport in real
time. Understanding the molecular mechanism and the dynamics of glutamate transport and its
regulation is important because these transporters not only contribute to controlling the time course of
the excitatory neurotransmitter in the synaptic cleft, thus indirectly modulating glutamatergic
transmission, but they can also directly regulate cell excitability through their anion channel function.
Furthermore, malfunctioning glutamate transporters have been implicated in several diseases of the
nervous system.
| Status | Finished |
|---|---|
| Effective start/end date | 07/1/08 → 06/30/09 |
Funding
- National Inst of Neurological Disorders & Stroke: $367,112.12
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.